Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO   US7142901039

PERRIGO COMPANY (PRGO)

6
 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company was formed as a part of merger between Perrigo Co. and Elan Corp. Plc as on December... 
Sector
Pharmaceuticals
Calendar
11/04Shareholder meeting
Surperformance© rating of Perrigo Company
Trading Rating : Investor Rating :
More about the company
Financials ($)
Sales 2015 4 479 M
EBIT 2015 1 246 M
Net income 2015 760 M
Debt 2015 1 508 M
Yield 2015 0,32%
Sales 2016 4 801 M
EBIT 2016 1 373 M
Net income 2016 909 M
Debt 2016 574 M
Yield 2016 0,36%
PER 2015 29,55
PER 2016 24,65
EV / Sales 2015 4,83x
EV / Sales 2016 4,31x
Capitalization 20 111 M
More Financials
Latest news on PERRIGO COMPANY
2d ago Actavis, Sanofi among bidders for Omega Pharma- Bloomberg
09/10 PERRIGO : Pharma Equities Technical Coverage - VIVUS, Auxilium Pharma, Depomed, ..
09/08 SAC's Martoma gets 9 years prison for insider trading
09/08 SAC's Martoma gets 9 years prison for insider trading
09/04 U.S. judge won't toss insider trading conviction of SAC's Martoma
08/27 PERRIGO COMPANY PLC : ex-dividend day
08/20 PERRIGO : New Drug Launches, Technical Updates, New Facility, Clinical Trials Da..
08/14 Cohen, Point72 must face SAC insider trading lawsuit-judge
08/05 PERRIGO : Introducing SENTRY® Petrodex® Advanced Dental Care Calming Kit for Dog..
07/30 Analysis - Ireland has too much to lose to deter U.S. companies re-homing
07/30 Ireland has too much to lose to deter U.S. companies re-homing
07/30 PERRIGO : Confirms First To File Patent Challenge For Generic Version Of Topicor..
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF